MedPath

Conjugated Hyperbilirubinemia and Pulse Oximetry

Not Applicable
Terminated
Conditions
Liver Disease
Hyperbilirubinemia
Registration Number
NCT00741117
Lead Sponsor
Emory University
Brief Summary

The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high levels of bilirubin in the blood on the accuracy of the pulse oximeter reading. Initial studies showed an underestimation of the oxygen concentration in the presence of elevated bilirubin. Subsequent studies have suggested that high levels of bilirubin in the blood do not influence the accuracy of the pulse oximeter machine. However, recent reports in bone marrow transplant literature and our personal observations in patients with liver disease suggest that high bilirubin levels are associated with an overestimation of the oxygen concentration as measured by the pulse oximeter machine.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Patients with established liver disease or dysfunction, as determined by abnormal liver function tests, imaging, or biopsy
Exclusion Criteria
  • Patients with unconjugated hyperbilirubinemia, which could be associated with elevations in carboxyhemoglobin
  • Patients with poor peripheral perfusion that would compromise accurate pulse oximetric determination

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Comparison of pulse oximetric saturation and calculated oxygen saturation.Enrollment visit
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

Emory University Hospital
🇺🇸Atlanta, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.